Evidence map›Paper›PMID 41214179›Full record

ArticleScientific reports2025

Impact of four-dimensional computed tomography phase number on target coverage of four-dimensional robustly optimized lung stereotactic body radiotherapy.

Takayuki Yagihashi, Tatsuya Inoue, Masashi Yamanaka, Shintaro Shiba, Akihiro Yamano, Naoki Sato, Yumiko Minagawa, Motoko Omura

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Takayuki YagihashiDepartment of Medical Physics, Shonan Kamakura General Hospital, 1370-1 Okamoto, Kamakura, Kanagawa, 247-8533, Japan.
Tatsuya InoueDepartment of Medical Physics, Shonan Kamakura General Hospital, 1370-1 Okamoto, Kamakura, Kanagawa, 247-8533, Japan. ttinoue@juntendo.ac.jp.
Masashi YamanakaDepartment of Medical Physics, Shonan Kamakura General Hospital, 1370-1 Okamoto, Kamakura, Kanagawa, 247-8533, Japan.
Shintaro ShibaDepartment of Radiation Oncology, Shonan Kamakura General Hospital, 1370-1 Okamoto, Kamakura, Kanagawa, 247-8533, Japan.
Akihiro YamanoDepartment of Medical Physics, Shonan Kamakura General Hospital, 1370-1 Okamoto, Kamakura, Kanagawa, 247-8533, Japan.
Naoki SatoDepartment of Medical Physics, Shonan Kamakura General Hospital, 1370-1 Okamoto, Kamakura, Kanagawa, 247-8533, Japan.
Yumiko MinagawaDepartment of Radiation Oncology, Shonan Kamakura General Hospital, 1370-1 Okamoto, Kamakura, Kanagawa, 247-8533, Japan.
Motoko OmuraDepartment of Radiation Oncology, Shonan Kamakura General Hospital, 1370-1 Okamoto, Kamakura, Kanagawa, 247-8533, Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

This study evaluated the dosimetric benefits of various four-dimensional (4D) robust optimization strategies for enhancing plan robustness in free-breathing stereotactic body radiotherapy (SBRT). For ten early-stage lung cancer patients, we generated four helical tomotherapy-SBRT plans (42 Gy/4 fractions) using 4D robust optimization based on 4D-computed tomography (CT) images from all ten phases (4D_10), six phases (4D_6), four phases (4D_4), and two phases (4D_2). Conventional internal target volume (ITV)-based plans served as a reference. Setup uncertainty robustness was assessed across all CT phases. We compared dose and target coverage (D

Indexed as

Four-Dimensional Computed TomographyLung NeoplasmsRadiosurgeryRadiotherapy Planning, Computer-AssistedHumansOrgans at RiskRadiotherapy DosageRadiotherapy, Intensity-Modulated4D robust optimizationFree-breathing radiotherapyLung cancerLung stereotactic body radiotherapyRayStationTomotherapy

Identifiers

PMID41214179
PMCPMC12603163

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.